Abstract
We previously demonstrated that the developmentally regulated gene,SOX6, is strongly expressed in glioma cells and in the fetal brain, but only faintly in the normal adult brain. Recent studies have indicated that brain tumor cells may share antigens, signaling systems, and behavior with neural stem/progenitor cells. To test the validity of this proposition, we analyzed the expression of SOX6 in various human central nervous system (CNS) tumors. Immunohistochemical analysis revealed that astrocytic and oligodendroglial tumors expressed SOX6; neuronal-glial cell tumors (central neurocytoma) and embryonal tumors (medulloblastoma), which arise from multipotential stem cell precursors, also showed a high intensity of SOX6 staining. In contrast, ependymal tumors (ependymoma and subependymoma), meningioma, and schwannoma, which are all well differentiated tumors, showed either no staining or only faint staining for SOX6. These results suggest that SOX6 may be expressed in bipotential or multipotential cells capable of neuronal and glial differentiation, but not in fully differentiated cells. SOX6 may be a useful marker for the diagnosis of tumors arising from immature bipotential cells that may differentiate into neuronal and glial cells.
Similar content being viewed by others
References
Holland EC (2001) Progenitor cells and glioma formation. Curr Opin Neurol 14:683–688
Dai C, Celestino JC, Okada Y, et al (2001) PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 15:1913–1925
Fults D, Pedone C, Dai C, et al (2002) MYC expression promotes the proliferation of neural progenitor cells in culture and in vivo. Neoplasia 4:32–39
Holland EC, Celestino J, Dai C, et al (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25:55–57
Dahlstrand J, Collins VP, Lendahl U (1992) Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res 52:5334–5341
Tohyama T, Lee VM, Rorke LB, et al (1992) Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab Invest 66:303–313
Ueda R, Iizuka Y, Yoshida K, et al (2004) Identification of a human glioma antigen, SOX6, recognized by patients' sera. Oncogene 23:1420–1427
Ueda R, Yoshida K, Kawakami Y, et al (2004) Expression of a transcriptional factor, SOX6, in human gliomas. Brain Tumor Pathol 21:35–38
Connor F, Wright E, Denny P, et al (1995) The Sry-related HMG box-containing gene Sox6 is expressed in the adult testis and developing nervous system of the mouse. Nucleic Acids Res 23:3365–3372
Hemmati HD, Nakano I, Lazareff JA, et al (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 100:15178–15183
Ignatova TN, Kukekov VG, Laywell ED, et al (2002) Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39:193–206
Leung C, Lingbeek M, Shakhova O, et al (2004) Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 428:337–341
Toda M, Iizuka Y, Yu W, et al (2001) Expression of the neural RNA-binding protein Musashi1 in human gliomas. Glia 34:1–7
Kleihues P, Louis DN, Scheithauer BW, et al (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215–225
Rao G, Pedone CA, Coffin CM, et al (2003) c-Myc enhances sonic hedgehog-induced medulloblastoma formation from nestin-expressing neural progenitors in mice. Neoplasia 5:198–204
Laudet V, Stehelin D, Clevers H (1993) Ancestry and diversity of the HMG box superfamily. Nucleic Acids Res 21:2493–2501
Prior HM, Walter MA (1996) SOX genes: architects of developmen. Mol Med 2:405–412
Wegner M (1999) From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res 27:1409–1420
Dyer MA (2004) Mouse models of childhood cancer of the nervous system. J Clin Pathol 57:561–576
Mendelsohn G, Maksem JA (1986) Divergent differentiation in neoplasms. Pathologic, biologic, and clinical considerations. Pathol Annu 21(Pt 1):91–119
Valdueza JM, Westphal M, Vortmeyer A, et al (1996) Central neurocytoma: clinical, immunohistologic, and biologic findings of a human neuroglial progenitor tumor. Surg Neurol 45:49–56
von Deimling A, Kleihues P, Saremaslani P, et al (1991) Histogenesis and differentiation potential of central neurocytomas. Lab Invest 64:585–591
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ueda, R., Yoshida, K., Kawakami, Y. et al. Immunohistochemical analysis of SOX6 expression in human brain tumors. Brain Tumor Pathol 21, 117–120 (2004). https://doi.org/10.1007/BF02482186
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02482186